C4 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	464	278	289	1,566	1,426	-	-
Market Cap Growth	-	-3.60%	-81.55%	9.83%	-	-	-
Enterprise Value	278	92	97	1,296	1,074	-79	-24
PE Ratio	-2.10	-2.10	-2.25	-18.66	-21.49	-	-
PS Ratio	22.34	13.42	9.29	34.20	42.95	-	-
PB Ratio	1.88	1.13	1.00	4.02	5.08	-	-
P/FCF Ratio	-2.57	-2.57	-2.59	-17.74	-21.00	-	-
P/OCF Ratio	-2.61	-2.61	-2.73	-18.00	-21.20	-	-
EV/Sales Ratio	13.37	4.45	3.11	28.31	32.36	-3.71	-1.26
EV/EBITDA Ratio	-0.76	-0.76	-0.82	-16.44	-17.08	2.60	2.01
EV/EBIT Ratio	-0.71	-0.71	-0.77	-15.85	-16.34	2.38	1.55
EV/FCF Ratio	-0.85	-0.85	-0.87	-14.69	-15.82	-1.46	1.24
Debt / Equity Ratio	0.29	0.29	0.30	0.11	0.08	-0.12	-0.18
Debt / EBITDA Ratio	-0.58	-0.58	-0.74	-0.54	-0.36	-0.45	-1.19
Debt / FCF Ratio	-0.65	-0.65	-0.78	-0.49	-0.34	0.25	-0.74
Quick Ratio	6.29	6.29	6.31	6.21	8.64	2.91	5.23
Current Ratio	6.34	6.34	6.46	6.36	8.69	2.88	5.16
Asset Turnover	0.06	0.06	0.07	0.10	0.13	0.16	-
Interest Coverage	-94.57	-94.57	-56.84	-38.11	-53.48	-	-
Return on Equity (ROE)	-55.30%	-55.30%	-38.90%	-22.90%	-78.60%	44.40%	-
Return on Assets (ROA)	-35.80%	-35.80%	-27.00%	-17.50%	-25.60%	-32.20%	-
Return on Capital (ROIC)	-43.85%	-43.85%	-34.42%	-18.99%	-19.90%	36.10%	25.11%
Earnings Yield	-28.57%	-47.58%	-44.37%	-5.36%	-4.65%	-	-
FCF Yield	-23.41%	-38.98%	-38.58%	-5.64%	-4.76%	-	-
Buyback Yield / Dilution	-1.59%	-1.59%	-6.12%	-304.93%	-728.80%	87.42%	-
Total Shareholder Return	-1.59%	-1.59%	-6.12%	-304.93%	-728.80%	87.42%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).